Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)

Clinical trial NCT01697956 · COMPLETED

Trial details

NCT number: NCT01697956
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2012-10-01
Primary completion: 2013-02-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.